Skip to main content

Definium Therapeutics, Inc. insider trading

DFTXNASDAQ
$37.40-0.20 (-0.53%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+206.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • RBRobert BarrowChief Executive Officer1.647%of company
  • DKDaniel KarlinChief Medical Officer0.5901%of company
  • MSMark SullivanChief Legal Officer0.3678%of company
  • BRBrandi RobertsChief Financial Officer0.2936%of company
  • MTMatthew T. WileyChief Commercial Officer0.2672%of company
  • CLCarrie LiaoChief Accounting Officer0.1079%of company
  • SLSuzanne Louise BruhnDirector0.0181%of company
  • RCRoger CrystalDirector0.0181%of company
  • CACarol A. ValloneDirector0.0166%of company
  • AKAndreas KrebsDirector0.0159%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
DFTXDaniel KarlinChief Medical OfficerOpen market sell$397K-1.4%$36.57$397KSep 25, 2026Sep 29, 2026
DFTXRobert BarrowChief Executive OfficerOpen market sell$1.15M-1.4%$36.57$1.15MSep 25, 2026Sep 29, 2026
DFTXMatthew T. WileyChief Commercial OfficerOpen market sell$113K-0.9%$36.57$113KSep 25, 2026Sep 29, 2026
DFTXMark SullivanChief Legal OfficerOpen market sell$514K-2.8%$36.57$514KSep 25, 2026Sep 29, 2026
DFTXBrandi RobertsChief Financial OfficerOpen market sell$123K-0.9%$36.57$123KSep 25, 2026Sep 29, 2026
DFTXRobert BarrowChief Executive OfficerOpen market sell$722K-1.3%$37.94$722KSep 3, 2026Sep 4, 2026
DFTXMark SullivanChief Legal OfficerOpen market sell$586K-3.9%$45.03$586KJun 25, 2026Jun 26, 2026
DFTXDaniel KarlinChief Medical OfficerOpen market sell$452K-2.0%$45.03$452KJun 25, 2026Jun 26, 2026
DFTXBrandi RobertsChief Financial OfficerOpen market sell$136K-1.4%$45.03$136KJun 25, 2026Jun 26, 2026
DFTXRobert BarrowChief Executive OfficerOpen market sell$1.32M-2.6%$45.03$1.32MJun 25, 2026Jun 26, 2026
DFTXMatthew T. WileyChief Commercial OfficerOpen market sell$129K-1.6%$45.03$129KJun 25, 2026Jun 26, 2026
DFTXDaniel KarlinChief Medical OfficerOpen market sell$148K-1.9%$18.47$148KMar 25, 2026Mar 26, 2026
DFTXMark SullivanChief Legal OfficerOpen market sell$198K-3.8%$18.47$198KMar 25, 2026Mar 26, 2026
DFTXRobert BarrowChief Executive OfficerOpen market sell$451K-3.1%$18.47$451KMar 25, 2026Mar 26, 2026
DFTXDaniel KarlinChief Medical OfficerOpen market sell$73.6K-1.3%$13.15$73.6KDec 26, 2025Dec 29, 2025
DFTXRobert BarrowChief Executive OfficerOpen market sell$339K-3.2%$13.15$339KDec 26, 2025Dec 29, 2025
DFTXMark SullivanChief Legal OfficerOpen market sell$148K-3.8%$13.15$148KDec 26, 2025Dec 29, 2025
End of history · 17 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.